Effect of Solvents and Crystallization Methods on the Formation of Carbamazepine-Saccharin Co-Crystal

  • Authors

    • Fatinah Ab Rahman
    • Engku N. Engku Mat Nasir
    • Syarifah Abd Rahim
    • Raihana Z. Edros
    • Nornizar Anuar
    2018-11-27
    https://doi.org/10.14419/ijet.v7i4.18.21828
  • Carbamazepine, Co-crystal, Polymorphic, Saccharin, Screening

  • Abstract

    Active Pharmaceutical Ingredients (API) crystallized in its co-crystal form is believed to be able to improve the physicochemical properties of its pure crystal. Carbamazepine (CBZ) and saccharin (SAC) were used in this study in investigation of effect of solvents and crystallization methods on the formation of CBZ-SAC co-crystal. There were four different solvents (acetonitrile, ethanol, ethyl acetate and propanol) and two crystallization methods (slurry and stirring crystallization) used in this study. The crystals produced were characterized by Differential Scanning Calorimetry (DSC), Powder X-Ray Diffraction (PXRD), Fourier Transform Infrared (FTIR) and optical microscopy. The findings revealed that only Form I of CBZ-SAC co-crystals was successfully formed for all parameters under studied. It was concluded that the type of solvents, crystallization methods and CBZ:SAC ratio used in this study did not play an important role on the CBZ-SAC Form I co-crystal formation for this system.  

     

  • References

    1. [1] Kitamura M (2002), Controlling factor of polymorphism in crystallization process, Journal of Crystal Growth 237-239, 2205-14.

      [2] Huang LF & Tong WQ (2004), Impact of solid state properties on developability assessment of drug candidates, Advanced Drug Delivery Reviews 56, 321-334.

      [3] Grzesiak AL, Lang M, Kim K & Matzger AJ (2003), Comparison of the four anhydrous polymorphs of carbamazepine and the crystal structure of Form I, Journal of Pharmaceutical Sciences 92, 2260-2271.

      [4] Fleischman SG, Kuduva SS, McMahon JA, Moultan B, Walsh RDB, Rodriguez-Hornedo N & Zaworotko MJ (2003), Crystal engineering of the composition of pharmaceutical phases: multiple-component crystalline solids involving carbamazepine, Crystal Growth & Design 3, 909-919.

      [5] Abd Rahim S, Tan CC & Ramle NA (2016), Carbamazepine-fumaric acid co-crystal screening using solution based method, MATEC Web of Conferences 69, 1-5.

      [6] Hickey MB, Peterson ML, Scoppettuolo LA, Morrisette LS, Vetter A, Guzman H, Remenar JF, Zhang Z, Tawa MD, Haley S, Zaworotko MJ & Almarsson O (2007), Performance comparison of a co-crystal of carbamazepine with marketed product, European Journal of Pharmaceutics and Biopharmaceutics 67, 112–119.

      [7] Kitamura M, Hayashi Y & Hara T (2008), Effects of solvent and molecular structure on the crystallization of polymorphs of BPT esters, Journal of Crystal Growth 310, 3067-3071.

      [8] Weissbuch I, Torbeev VY, Leiserowitz L & Lahav M (2005), Solvent effect on crystal polymorphism: why addition of methanol or ethanol to aqueous solutions induces the precipitation of the least

      stable β form of glycineâ€, Angewandte Chemie Interational Edition 44, 3226-3229.

      [9] Du W, Yin Q, Gong J, Bao Y, Zhang X, Sun X, Ding S, Xie C, Zhang M & Hao H (2014), Effects of solvent on polymorph formation and nucleation of prasugrel hydrochloride, Crystal Growth & Design 14, pp.4519-4525.

      [10] Lee MJ, Wang IC, Kim MJ, Kim P, Song KH, Chun NH, Park HG & Choi GJ (2015), Controlling the polymorphism of carbamazepine-saccharin cocrystals formed during antisolvent cocrystallization using kinetic parameters, Korean Journal of Chemical Engineering 32, 1910-1917.

      [11] Porter III WW, Elie SC & Matzger AJ (2008), Polymorphism in carbamazepine cocrystals, Crystal Growth & Design 8, pp.14-16.

      [12] Bag PP, Patni M & Reddy CM (2011), A kinetically controlled crystallization process for identifying new co-crystal forms: fast evaporation of solvent from solutions to dryness, CrystEngComm 13, 5650-5652.

      [13] Schultheiss N & Newman A (2009), Pharmaceutical cocrystals and their physicochemical properties, Crystal Growth & Design 9, 2950-2967.

      [14] Abd Rahim S, Ab Rahman F, Nasir ENEM & Ramle NA (2015), Carbamazepine co-crystal screening with dicarboxylic acids co-crystal formers, World Academy of Science, Engineering and Technology, International Science Index 101, International Journal of Environmental, Chemical, Ecological, Geological and Geophysical Engineering 9, 425-428.

      [15] Wang I-C, Lee M-J, Sim S-J, Kim W-S, Chun N-H & Choi GJ (2013), Anti-solvent co-crystallization of carbamazepine and saccharin, International Journal of Pharmaceutics 450, 311-322.

      [16] Pagire SK, Korde SA, Whiteside BR, Kendrick J & Paradkar A (2013), Spherical crystallization of carbamazepine/saccharin co-crystals: selective agglomeration and purification through surface interactions, Crystal Growth & Design 13, 4162-4167.

      [17] Kudo S & Takiyama H (2014), Production method of carbamazepine/saccharin cocrystal particles by using two solution mixing based on the ternary phase diagram, Journal of Crystal Growth 392, 87-91.

      [18] Abd Rahim S, Hammond RB, Sheikh AY & Robert KJ (2013), A comparative assessment of the influence of different crystallization screening methodologies on the solid forms of carbamazepine co-crystals, CrystEngComm 15, 3862-3873.

      [19] Rahman Z, Agarabi C, Zidan AS, Khan SR & Khan MA (2011), Physico-mechanical and Stability Evaluation of Carbamazepine Cocrystal with Nicotinamide, American Association of Pharmaceutical Scientists PharmSciTech 12, 693-704.

      [20] Jayasankar A, Somwangthanaroj A, Shao ZJ & Rodriguez-Hornedo N (2006), Cocrystal formation during cogrinding and storage is mediated by amorphous phase, Pharmaceutical Research 23,.2381-2392.

      [21] Lin H-L, Huang Y-T & Lin S-Y (2016), Spectroscopic and thermal approaches to investigate the formation mechanism of piroxicam-saccharin co-crystal induced by liquid-assisted grinding or thermal stress, Journal of Thermal Analysis and Calorimetry 123, 2345-2356.

  • Downloads

  • How to Cite

    Ab Rahman, F., N. Engku Mat Nasir, E., Abd Rahim, S., Z. Edros, R., & Anuar, N. (2018). Effect of Solvents and Crystallization Methods on the Formation of Carbamazepine-Saccharin Co-Crystal. International Journal of Engineering & Technology, 7(4.18), 90-94. https://doi.org/10.14419/ijet.v7i4.18.21828

    Received date: 2018-11-27

    Accepted date: 2018-11-27

    Published date: 2018-11-27